{"id":"W2025391536","doi":"10.1182/blood-2013-12-538975","title":"PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Fludarabine; PTK2; Oncology; Rituximab; Cyclophosphamide; Immunology; Cancer research; Leukemia; Chemotherapy; Lymphoma; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000442252,0.0002029022,0.0004314812,0.0001769098,0.0000548823,0.00002906335,0.0001547361,0.0001735633,0.0001166954],"category_scores_gemma":[0.0001908272,0.0001679221,0.00006816642,0.0002135405,0.0001288103,0.00007836928,0.0001129727,0.0002405384,0.00008893634],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0312278,"about_ca_system_score_gemma":0.008117663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007206707,"about_ca_topic_score_gemma":0.0000302301,"domain_scores_codex":[0.9982784,0.00007324517,0.0003699488,0.000405022,0.0003775172,0.000495902],"domain_scores_gemma":[0.9989536,0.0001700797,0.00006018774,0.000596954,0.00003845339,0.0001807646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009886128,0.0005270247,0.03447752,0.002021562,0.0002273408,0.0005963065,0.001426561,0.0002141453,0.9211938,0.0005625804,0.0009488256,0.03681569],"study_design_scores_gemma":[0.413081,0.00151685,0.04567297,0.001656227,0.0002123136,0.002008788,0.000163396,0.07266401,0.4472386,0.0006581354,0.01414272,0.0009849281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940442,0.002282366,0.00005925566,0.00007444507,0.00005598307,0.0003791095,0.000001114085,0.00008184104,0.003021691],"genre_scores_gemma":[0.9971467,0.0003864945,0.0005785778,0.000278482,0.000231236,0.0000394067,0.000008407315,0.00004695582,0.001283754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4739552,"threshold_uncertainty_score":0.9975054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01668731043829636,"score_gpt":0.2965285665735104,"score_spread":0.279841256135214,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}